Novartis' OAV101 IT gene therapy showed positive results in Phase 3 trials for SMA, with data supporting its potential as a ...

A pair of clinical data sets gives Novartis confidence in a new formulation of the company’s gene therapy Zolgensma for the ...

This season has indeed turned into a disaster for Miami, and it is every bit as bad as it seems. Only the Jazz (0-8), Nets (1-7) and Mavericks (1-7) have been o ...

Each team's No. 1 pass-catcher will be graded on a 15-point scale. The No. 2 pass-catcher will be graded on a 12-point scale, ...

With 288 GB of capacity across eight stacks of HBM3e memory onboard, a single Blackwell Ultra GPU can now run substantially ...

New Dynamo software splits AI inference across 1,000 GPUs to boost query throughput - Nvidia's answer to investor concerns ...

Twice-daily application of ruxolitinib cream demonstrated an ability to reduce itching and blistering in prurigo nodularis, a ...

High tech companies always have roadmaps. Whether or not they show them to the public, they are always showing them to key ...

Investors are rushing to invest in quantum computing, perhaps the next big idea to fuel the artificial intelligence ...

Immunovant and Roivant Sciences said Wednesday their rare disease drug succeeded in a final-phase study, but the duo won't seek approval.

The Avon Recreation Center is long overdue for a large-scale remodel. It looks like the fitness center and community ...

Data on meal sharing has been analysed together with data on wellbeing for the first time Globally, meal sharing as an indicator of self-reported wellbeing was on a par with income and employment ...